NM_000747.3:c.1365+17T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000747.3(CHRNB1):​c.1365+17T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.157 in 1,610,586 control chromosomes in the GnomAD database, including 21,098 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2231 hom., cov: 31)
Exomes 𝑓: 0.16 ( 18867 hom. )

Consequence

CHRNB1
NM_000747.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.530

Publications

13 publications found
Variant links:
Genes affected
CHRNB1 (HGNC:1961): (cholinergic receptor nicotinic beta 1 subunit) The muscle acetylcholine receptor is composed of five subunits: two alpha subunits and one beta, one gamma, and one delta subunit. This gene encodes the beta subunit of the acetylcholine receptor. The acetylcholine receptor changes conformation upon acetylcholine binding leading to the opening of an ion-conducting channel across the plasma membrane. Mutations in this gene are associated with slow-channel congenital myasthenic syndrome. [provided by RefSeq, Jul 2008]
CHRNB1 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 2C
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • congenital myasthenic syndrome 1A
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • congenital myasthenic syndrome 2A
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 17-7455958-T-C is Benign according to our data. Variant chr17-7455958-T-C is described in ClinVar as Benign. ClinVar VariationId is 256773.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.204 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000747.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNB1
NM_000747.3
MANE Select
c.1365+17T>C
intron
N/ANP_000738.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNB1
ENST00000306071.7
TSL:1 MANE Select
c.1365+17T>C
intron
N/AENSP00000304290.2
CHRNB1
ENST00000536404.6
TSL:2
c.1149+17T>C
intron
N/AENSP00000439209.2
CHRNB1
ENST00000576360.1
TSL:3
c.1002+17T>C
intron
N/AENSP00000459092.1

Frequencies

GnomAD3 genomes
AF:
0.167
AC:
24960
AN:
149786
Hom.:
2221
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.157
Gnomad AMI
AF:
0.146
Gnomad AMR
AF:
0.198
Gnomad ASJ
AF:
0.101
Gnomad EAS
AF:
0.197
Gnomad SAS
AF:
0.214
Gnomad FIN
AF:
0.253
Gnomad MID
AF:
0.0962
Gnomad NFE
AF:
0.151
Gnomad OTH
AF:
0.153
GnomAD2 exomes
AF:
0.175
AC:
43979
AN:
250924
AF XY:
0.174
show subpopulations
Gnomad AFR exome
AF:
0.148
Gnomad AMR exome
AF:
0.212
Gnomad ASJ exome
AF:
0.101
Gnomad EAS exome
AF:
0.188
Gnomad FIN exome
AF:
0.244
Gnomad NFE exome
AF:
0.149
Gnomad OTH exome
AF:
0.167
GnomAD4 exome
AF:
0.156
AC:
228471
AN:
1460716
Hom.:
18867
Cov.:
34
AF XY:
0.157
AC XY:
114433
AN XY:
726680
show subpopulations
African (AFR)
AF:
0.147
AC:
4914
AN:
33420
American (AMR)
AF:
0.212
AC:
9481
AN:
44658
Ashkenazi Jewish (ASJ)
AF:
0.0999
AC:
2609
AN:
26104
East Asian (EAS)
AF:
0.201
AC:
7950
AN:
39622
South Asian (SAS)
AF:
0.214
AC:
18431
AN:
86230
European-Finnish (FIN)
AF:
0.239
AC:
12737
AN:
53342
Middle Eastern (MID)
AF:
0.0810
AC:
467
AN:
5764
European-Non Finnish (NFE)
AF:
0.146
AC:
162320
AN:
1111232
Other (OTH)
AF:
0.158
AC:
9562
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
9784
19568
29351
39135
48919
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5940
11880
17820
23760
29700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.167
AC:
24990
AN:
149870
Hom.:
2231
Cov.:
31
AF XY:
0.173
AC XY:
12625
AN XY:
73072
show subpopulations
African (AFR)
AF:
0.157
AC:
6340
AN:
40356
American (AMR)
AF:
0.199
AC:
2997
AN:
15058
Ashkenazi Jewish (ASJ)
AF:
0.101
AC:
347
AN:
3452
East Asian (EAS)
AF:
0.197
AC:
998
AN:
5062
South Asian (SAS)
AF:
0.215
AC:
1023
AN:
4756
European-Finnish (FIN)
AF:
0.253
AC:
2565
AN:
10152
Middle Eastern (MID)
AF:
0.0931
AC:
27
AN:
290
European-Non Finnish (NFE)
AF:
0.151
AC:
10225
AN:
67744
Other (OTH)
AF:
0.160
AC:
336
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1020
2041
3061
4082
5102
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
276
552
828
1104
1380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.143
Hom.:
1944
Bravo
AF:
0.158
Asia WGS
AF:
0.269
AC:
933
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 19, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Congenital myasthenic syndrome 2A Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
6.7
DANN
Benign
0.50
PhyloP100
-0.53
PromoterAI
0.0091
Neutral
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2302763; hg19: chr17-7359277; COSMIC: COSV60139438; COSMIC: COSV60139438; API